Zai Lab

The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
Endpoints
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Flag link:
Biopharma Companies Entering 2021 With New Collabs, Partnerships
Biopharma Companies Entering 2021 With New Collabs, Partnerships
BioSpace
M&A
Argenx
Zai Lab
Dewpoint Therapeutics
Pfizer
CureVac
Bayer
Sanofi
Nurix Therapeutics
Flag link:
Corporate and regulatory developments over the holidays
Corporate and regulatory developments over the holidays
EP Vantage
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
Flag link:
Zai builds cancer combo strategy with rights to Incyte's PD-1 mAb
Zai builds cancer combo strategy with rights to Incyte's PD-1 mAb
BioCentury
Zai Lab
China
PD-1 inhibitors
Incyte
Flag link:
With potential launches nearing, Zai taps investors for $200M
With potential launches nearing, Zai taps investors for $200M
BioCentury
Zai Lab
China
drug launches
Flag link:
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
CP Wire
Five Prime
Zai Lab
bemarituzumab
gastric cancer
Flag link:
First Patient Dosed in Ph III Trial of Bemarituzumab for Advanced Gastric and Gastroesophageal Junction Cancers
Five Prime
Zai Lab
bemarituzumab
gastric cancer
Flag link:
Zai Lab bombs Phase IIa trial in atopic dermatitis, junks the program to shift resources to the pipeline
Zai Lab bombs Phase IIa trial in atopic dermatitis, junks the program to shift resources to the pipeline
Endpoints
Zai Lab
ZL-3101
Fugan
eczema
Shanghai
clinical trials
Flag link:
Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China
Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China
Endpoints
Zai Lab
AstraZeneca
China
Flag link:
Unstoppable growth of Chinese biotechs attracts over $10bn funding
Unstoppable growth of Chinese biotechs attracts over $10bn funding
GoinPharma
China
biotech
Zensun
BeiGene
Chi-Med
Zai Lab
WuXi
Flag link: